Compare
Can-Fite BioPharma Ltd. vs Medicinova Inc vs America Great Health vs Scienture Holdings, Inc.
| Latest fiscal year | Can-Fite BioPharma Ltd. CANF | Medicinova Inc MNOV | America Great Health AAGH | Scienture Holdings, Inc. SCNX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-06-30 | 2025-12-31 |
| Revenue | $405.0K | $409.7K | $391.7K | $431.6K |
| Revenue growth (YoY) | -39.9% | n/a | +32.9% | +215.9% |
| Gross margin | n/a | n/a | 86.6% | 76.8% |
| Operating margin | n/m | n/m | -97.8% | n/m |
| Net margin | n/m | n/m | -183.6% | n/m |
| Net income | -$9.83M | -$12.00M | -$719.1K | -$41.51M |
| EPS (Diluted) | -$5.97 | -$0.24 | $0.00 | -$2.70 |
| Operating cash flow | -$8.95M | -$9.81M | -$332.9K | -$13.38M |
| Free cash flow | -$8.95M | -$9.81M | n/a | n/a |
| Cash & equivalents | $5.53M | $30.81M | n/a | $6.66M |
| Total assets | $9.51M | $45.60M | $301.8K | $84.18M |
| Total liabilities | n/a | $4.02M | $6.05M | $14.06M |
| Shareholders' equity | $5.59M | $41.59M | -$5.66M | $70.12M |
| Return on year-end equity | -175.8% | -28.9% | n/a | -59.2% |
| Shares outstanding | 2.62M | 49.22M | 21.15B | 40.63M |
Revenue, most recent five fiscal years
| Fiscal year | Can-Fite BioPharma Ltd. | Medicinova Inc | America Great Health | Scienture Holdings, Inc. |
|---|---|---|---|---|
| Latest | $405.0K Ended 2025-12-31 | $409.7K Ended 2025-12-31 | $391.7K Ended 2025-06-30 | $431.6K Ended 2025-12-31 |
| 1 year earlier | $674.0K Ended 2024-12-31 | n/a | $294.7K Ended 2024-06-30 | $136.6K Ended 2024-12-31 |
| 2 years earlier | $743.0K Ended 2023-12-31 | $1.00M Ended 2023-12-31 | $204.3K Ended 2023-06-30 | $1.36M Ended 2023-12-31 |
| 3 years earlier | $810.0K Ended 2022-12-31 | n/a | $104.6K Ended 2022-06-30 | $10.25M Ended 2022-12-31 |
| 4 years earlier | $853.0K Ended 2021-12-31 | $4.04M Ended 2021-12-31 | $195.7K Ended 2021-06-30 | $9.89M Ended 2021-12-31 |